Sino Shenchang received a new round of investment of RMB 100 million
Sino-Shenchang is a high-end neurointerventional device developer. The company integrates R&D, production and sales. Its business covers three major fields of neurointerventional ischemia, hemorrhage and access. The products include: the world’s first NOVA intracranial drug-eluting stent System, the first domestic rapid exchange balloon Neuro RX for intracranial stenosis, and the first domestic low-named pressure rapid […]
Sino Shenchang received a new round of investment of RMB 100 million Read More »